인스타그램에서의 페르소나와 패션을 통한 자기표현에 관한 연구 -20~30대 여성을 중심으로-

원연정 ( Yeon Jung Won ),신은정 ( Eun Jung Shin ),고애란 ( Ae-ran Koh ) 한국의류학회 2021 한국의류학회지 Vol.45 No.5

This study qualitatively explored the case of users utilizing multiple accounts on one social network service to create their own multiple spaces and different personas. The purpose of the study was to understand the behavior of people who use multiple accounts to express their identity online using Carl Jung's personality theory. We used in-depth interviews and the Zaltman metaphor elicitation technique (ZMET), targeting 19 people in their 20s and 30s who use more than one personal account on Instagram. Creating a shared consensus map using the configuration concept of ZMET derived six personas in relation to Instagram accounts. The motivations for the respondents' self-presentation associated with their personas and self-presentation types shown on Instagram were analyzed in terms of persona and fashion and subdivided into five dimensions: relationship management strategic presentation, self-monitoring presentation, competence demonstration presentation, anonymous presentation, and persona-centered presentation. Each respondent's persona and self-presentation formed by the Instagram account was analyzed.

오공약침의 안전성에 대한 임상적 연구

소기숙,최회강,박소영,고강훈,김성남,이옥자,윤민영,문형철,김성철,이정훈,나원경,So, Ki-suk,Choi, Hoi-kang,Park, So-young,Koh, Kang-hun,Kim, Sung-nam,Lee, Ok-ja,Yun, Min-young,Mun, Hyung-chul,Kim, Sung-chul,Lee, Jung-hun,Na, Won-kyung 대한침구의학회 2004 대한침구의학회지 Vol.21 No.1

Objective: Recently scolopendrid aquacupuncture has been a good effect on pain control but it has not been known about clinical safety. So, In order to prove the clinical safety of scolopendrid aquacupuncture, We have observed the physical reac-tion and clinical pathology test after scolopendrid aquacupuncture treatment. Methods: We analyzed physical reaction and clinical pathology test before and after Scolopendrid aquacupuncture treatment of 30 patients suffering from pain, who admitted department of Acupunture and Moxibustion, College of Oriental Medicine, Won-Kwang University Kwangju hospital. Results & Conclusions: The results were summarized as follows. 1) The distribution of sex was 14 males and 16 females, and the average of patients age was 46.2 years. 2) The distribution of symptom was lumbago, lumbago with radiating pain, nuchal pain and knee joint pain. 3) In the 30 patients treated with Scolopendrid aquacupuncture, hematologic test did not show remarkable change. 4) In the 30 patients treated with Scolopendrid aquacupuncture, Liver function test(AST, ALT, ALP) showed a slight decrease on the contrary, and abnormal rate showed a decrease of 1.0%(from 3.3% to 2.3%) compared with previous study. 5) In the 30 patients treated with Scolopendrid aquacupuncture, Renal function test(BUN, Cr) and abnormal rate(from 2.5% to 2.0%) showed a slight decrease on the contrary. 6) In the 30 patients treated with Scolopendrid aquacupuncture. Electrolyte were normal range before & after treatment. 7) In the results of the Urine analysis of 30 patients, Leukocyte, Protein. Glucose, Keton, Bilirubin, U-bilinogen were not detected before and after Scolopendrid aquacupuncture treatment, and the rest almost made no difference. 8) In the Physical reactions, all of the patients complained of pain of body partially, only one patient showed reddish and itch, but symptoms like those were entirely disappeared within 24 hours and whole body pain, swelling, headache, dizziness, fatigue and nausea was not observed.

The Korean Academy of Tuberculosis and Respiratory Diseases : Slide Session ; OS-090 : COPD ; Emphysema Is a Risk Factor for Severe Pneumonia in Patients with Chronic Obstructive Pulmonary Disease

( Won Jun Song ),( Jung Seop Eom ),( Hong Seok Yoo ),( Byeong Ho Jeong ),( Ho Yun Lee ),( Won Jung Koh ),( Kyeong Man Jeon ),( Hye Yun Park ) 대한내과학회 2014 대한내과학회 추계학술대회 Vol.2014 No.1

Background: Because chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder, various factors could be associated with the severity of pneumonia in patients with COPD. Therefore, we examined the risk factors associated with severe pneumonia in a COPD population. Methods: A retrospective observational study with a prospectively collected database of community-acquired pneumonia (CAP) was conducted between 2008 and 2012. Patients with hospital-acquired pneumonia, immunocompromised patients, and those without a baseline computed tomography (CT) scan were excluded. As a result, 150 patients with COPD and CAP were included. Results: Of the 150 patients, 106 (70.7%) and 44 (29.3%) were classified with non-severe and severe pneumonia, respectively. A multivariate logistic regression analysis revealed that the presence of pulmonary emphysema on a CT scan (odds ratio, 2.933; 95% confi dence interval, 1.144 7.516; P = 0.025) was independently associated with severe pneumonia in patients with COPD. However, no signifi cant difference in severity of the air ow limitation, presence of bronchiectasis, previous COPD medicationincluding inhaled corticosteroids, or pathogens was identifi ed between those with non-severe and severe pneumonia. Conclusions: The presence of pulmonary emphysema on a CT scan at the time of admission to the hospital of a patient with COPD was independently associated with severe pneumonia in a COPD population.

Tin Oxide Thin Film Deposition for Gas Sensor by Reactive Ionized Cluster Beam(R - ICB)

Won-Kook Choi,Seok-Kyun Song,Hyung-Jin Jung,Seok-Keun Koh,Dongsoo Choi 한국진공학회 1995 한국진공학회 학술발표회초록집 Vol.- No.-

Mycobacterial Characteristics and Treatment Outcomes in <i>Mycobacterium abscessus</i> Lung Disease

Koh, Won-Jung,Jeong, Byeong-Ho,Kim, Su-Young,Jeon, Kyeongman,Park, Kyoung Un,Jhun, Byung Woo,Lee, Hyun,Park, Hye Yun,Kim, Dae Hun,Huh, Hee Jae,Ki, Chang-Seok,Lee, Nam Yong,Kim, Hong Kwan,Choi, Yong So Oxford University Press 2017 Clinical Infectious Diseases Vol. No.

<P><B>Summary.</B></P><P>Several mycobacterial characteristics, including colony morphotype, susceptibility to macrolide antibiotics, and T28C substitution in the <I>erm</I>(41) gene, are helpful in predicting the treatment responses of patients with <I>Mycobacterium abscessus</I> lung disease. Treatment failures and recurrences are frequently caused by reinfection.</P><P><B>Background.</B></P><P>Treatment outcomes of patients with <I>Mycobacterium abscessus</I> subspecies <I>abscessus</I> lung disease are poor, and the microbial characteristics associated with treatment outcomes have not been studied systematically. The purpose of this study was to identify associations between microbial characteristics and treatment outcomes in patients with <I>M. abscessus</I> lung disease.</P><P><B>Methods.</B></P><P>Sixty-seven consecutive patients with <I>M. abscessus</I> lung disease undergoing antibiotic treatment for ≥12 months between January 2002 and December 2012 were included. Morphotypic and genetic analyses were performed on isolates from 44 patients.</P><P><B>Results.</B></P><P>Final sputum conversion to culture negative occurred in 34 (51%) patients. Compared to isolates from 24 patients with persistently positive cultures, pretreatment isolates from 20 patients with final negative conversion were more likely to exhibit smooth colonies (9/20, 45% vs 2/24, 8%; <I>P</I> = .020), susceptibility to clarithromycin (7/20, 35% vs 1/24, 4%; <I>P</I> = .015), and be of the C28 sequevar with regard to the <I>erm</I>(41) gene (6/20, 30% vs 1/24, 4%; <I>P</I> = .035). <I>Mycobacterium abscessus</I> lung disease recurred in 5 (15%) patients after successful completion of antibiotic therapy. Genotypic analysis revealed that most episodes (22/24, 92%) of persistently positive cultures during antibiotic treatment and all cases of microbiologic recurrence after treatment completion were caused by different <I>M. abscessus</I> genotypes within a patient.</P><P><B>Conclusions.</B></P><P>Precise identification to the subspecies level and analysis of mycobacterial characteristics could help predict treatment outcomes in patients with <I>M. abscessus</I> lung disease. Treatment failures and recurrences are frequently associated with multiple genotypes, suggesting reinfection.</P><P><B>Clinical Trials Registration.</B></P><P>NCT00970801.</P>

이온 클러스터빔에의한 구리박막제작

Won-Kook Choi,Ki-Han Kim,Young-Soo Yoon,Jiyun Lee,Hyung-Jin Jung,Seok-Keun Koh 한국진공학회 1995 한국진공학회 학술발표회초록집 Vol.- No.-

Laparoscopic restaging surgery in patient with unexpected uterine cancer

( Won Moo Lee ),( Jae Man Bae ),( A Ra Koh ),( Un Suk Jung ),( Jung Hwa Ko ),( Joong Sub Choi ) 대한산부인과학회 2015 대한산부인과학회 학술대회 Vol.101 No.-

Outcomes of Arthroscopic Scaphoid Excision and Lunocapitate Fusion for Advanced Traumatic Arthritis of the Wrist

Won-Taek Oh,Heon-Jung Park,Il-Hyun Koh,Yun-Rak Choi 대한정형외과학회 2023 Clinics in Orthopedic Surgery Vol.15 No.2

Background: Arthroscopic lunocapitate (LC) fusion can be an alternative surgical treatment for scapholunate advanced collapse (SLAC) or scaphoid nonunion advanced collapse (SNAC) of the wrist. We retrospectively reviewed patients who had arthroscopic LC fusion to estimate clinical and radiological outcomes. Methods: From January 2013 to February 2017, all patients with SLAC (stage II or III) or SNAC (stage II or III) wrists, who underwent arthroscopic LC fusion with scaphoidectomy and were followed up for a minimum of 2 years, were enrolled in this retrospective study. Clinical outcomes included visual analog scale (VAS) pain, grip strength, active range of wrist motion, Mayo wrist score (MWS), and the Disabilities of Arm, Shoulder and Hand (DASH) score. Radiologic outcomes included bony union, carpal height ratio, joint space height ratio, and loosening of screws. We also performed group analysis between patients with 1 and 2 headless compression screws to fix the LC interval. Results: Eleven patients were assessed for 32.6 ± 8.0 months. Union was achieved in 10 patients (union rate, 90.9%). There was improvmenet in mean VAS pain score (from 7.9 ± 1.0 to 1.6 ± 0.7, p = 0.003) and grip strength (from 67.5% ± 11.4% to 81.8% ± 8.0%, p = 0.003) postoperatively. The mean MWS and DASH score were 40.9 ± 13.8 and 38.3 ± 8.2, respectively, preoperatively and improved to 75.5 ± 8.2 and 11.3 ± 4.1, respectively, postoperatively (p < 0.001 for all). Radiolucent screw loosening occurred in 3 patients (27.3%), including 1 nonunion patient and 1 patient who underwent screw removal due to the screw migration encroaching the lunate fossa of radius. In group analysis, only the frequency of radiolucent loosening was higher in 1 screw (3 of 4) than 2 screw fixation (0 of 7) (p = 0.024). Conclusions: Arthroscopic scaphoid excision and LC fusion for patients with advanced SLAC or SNAC of the wrist was effective and safe only in cases fixed with 2 headless compression screws. We recommend arthroscopic LC fusion using 2 screws rather than 1 to decrease radiolucent loosening, which might affect complications such as nonunion, delayed union, or screw migration.

Diagnosis and Treatment of Nontuberculous Mycobacterial Pulmonary Diseases: A Korean Perspective

Koh, Won-Jung,Kwon, O Jung,Lee, Kyung Soo The Korean Academy of Medical Sciences 2005 JOURNAL OF KOREAN MEDICAL SCIENCE Vol.20 No.6

<P>The incidence of pulmonary disease caused by nontuberculous mycobacteria (NTM) appears to be increasing worldwide. In Korea, <I>M. avium</I> complex and <I>M. abscessus</I> account for most of the pathogens encountered, whilst <I>M. kansasii</I> is a relatively uncommon cause of NTM pulmonary diseases. NTM pulmonary disease is highly complex in terms of its clinical presentation and management. Because its clinical features are indistinguishable from those of pulmonary tuberculosis and NTMs are ubiquitous in the environment, the isolation and identification of causative organisms are mandatory for diagnosis, and some specific diagnostic criteria have been proposed. The treatment of NTM pulmonary disease depends on the infecting species, but decisions concerning the institution of treatment are never easy. Treatment requires the use of multiple drugs for 18 to 24 months. Thus, treatment is expensive, often has significant side effects, and is frequently not curative. Therefore, clinicians should be confident that there is sufficient pathology to warrant prolonged, multidrug treatment regimens. In all of the situations, outcomes can be best optimized only when clinicians, radiologists, and laboratories work cooperatively.</P>

The Korean Academy of Tuberculosis and Respiratory Diseases : Slide Session ; OS-101 : Critical Care ; Comparison of Clinical Outcomes Between Patients Initiated with Peramivir and those with Osteltamivir Hospitalized to Intensive Care Unit Due to Severe

( Jung Wan Yoo ),( Sang Ho Choi ),( Jin Won Huh ),( Chae Man Lim ),( Youn Suck Koh ),( Sang Bum Hong ) 대한내과학회 2014 대한내과학회 추계학술대회 Vol.2014 No.1

Background: Peramivir, intravenous neuraminidase inhibitor, is available to treat in- uenza in hospitalized patients in South Korea. Whether it provides clinical benefi ts to the critically ill patients with severe in uenza infection admitted to intensitve care unit (ICU)compared to oral oseltamivir remains unclear. Methods: From August 2009 through March 2014, Patients = 18 confi rmed with laboratory evidence of in uenza infection and hospitalized to medical ICU more than 24 hours were enrolled at Asan Medical Center. Study was performed retrospectively Results: Ninety six patients were enrolled; 38 and 58 received peramivir and oseltamivir initially, respectively. SOFA score was higher in patients initiated with peramivir. More clinical complications including shock (68.4 vs 44.8%), acute kidney injury (44.7 vs 22.4%) and hospital acquired pneumonia (47.4 vs 27.6%) developed in patients receiving peramivir initially. There was no difference of median duration of use of antiviral agents between two groups (10 days in both groups). More triple combination antiviral agents were prescribed in patients initiated with oseltamivir (36.2 vs 7.9%,P=0.002) while more vasopressors (78.9 vs 44.8%, P=0.001) was used in those initiated with peramivir. There were no signifi cant differences including median length of ICU (20.5 in peramivir vs 17 days in oseltamivir, P=0.284) and 28-day mortality (36.8% [14/38] in peramivir vs 34.5% [20/58] in oseltamivir, P=0.813). Acute heart failure (Oddsratio [OR] 3.668, 95% Confi dence Interval [CI], 1.134-11.870, P=0.03), hospital acquired pneumonia (OR 4.197, 95% CI, 1.578-11.161, P=0.004) and use of corticosteroid (OR 3.022, 95% CI, 1.169-7.812, P=0.022) were associated with 28-day mortality. Conclusions: Peramivir may be an optional antiviral agent to treat the critically ill patients with severe in uenza infection and hospitalized to ICU.